Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,175 | -7,661 | -3,492 | -9,856 | -6,150 |
| Depreciation Amortization | -66 | -197 | -30 | 243 | 180 |
| Accounts receivable | -680 | -487 | -199 | -63 | -131 |
| Accounts payable and accrued liabilities | 675 | 415 | -466 | -604 | -1,171 |
| Other Working Capital | -5 | -72 | -665 | -1,205 | -1,840 |
| Other Operating Activity | 1,380 | 999 | 1,031 | 2,462 | 2,339 |
| Operating Cash Flow | $-10,871 | $-7,003 | $-3,821 | $-9,023 | $-6,773 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 77,517 | 77,248 | 16,930 | 32,354 | 27,907 |
| PPE Investments | -9 | -4 | -4 | -90 | -53 |
| Purchase Of Investment | -72,600 | -68,717 | N/A | -92,279 | -88,180 |
| Investing Cash Flow | $4,908 | $8,527 | $16,926 | $-60,015 | $-60,326 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 95 | 95 | 74 | 80,176 | 80,061 |
| Financing Cash Flow | $95 | $95 | $74 | $80,176 | $80,061 |
| Beginning Cash Position | 24,159 | 24,159 | 24,159 | 13,021 | 13,021 |
| End Cash Position | 18,291 | 25,778 | 37,338 | 24,159 | 25,983 |
| Net Cash Flow | $-5,868 | $1,619 | $13,179 | $11,138 | $12,962 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,871 | -7,003 | -3,821 | -9,023 | -6,773 |
| Capital Expenditure | -9 | -4 | -4 | -90 | -53 |
| Free Cash Flow | -10,880 | -7,007 | -3,825 | -9,113 | -6,826 |